Total Payments
$1,172
2024 Payments
$39.42
Companies
20
Transactions
74
Medicare Patients
6,278
Medicare Billing
$655,731
Payment Breakdown by Category
Food & Beverage$1,169 (99.8%)
Education$2.69 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,169 | 73 | 99.8% |
| Education | $2.69 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $134.39 | 10 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $116.97 | 1 | $0 (2018) |
| AbbVie Inc. | $116.93 | 6 | $0 (2021) |
| GlaxoSmithKline, LLC. | $98.53 | 7 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $98.47 | 7 | $0 (2024) |
| Lilly USA, LLC | $94.46 | 7 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $72.33 | 5 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $56.15 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $52.86 | 3 | $0 (2022) |
| Astellas Pharma US Inc | $47.93 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.42 | 2 | AstraZeneca Pharmaceuticals LP ($20.44) |
| 2023 | $15.87 | 1 | PFIZER INC. ($15.87) |
| 2022 | $79.48 | 4 | Novartis Pharmaceuticals Corporation ($39.01) |
| 2021 | $101.17 | 5 | AbbVie Inc. ($101.17) |
| 2020 | $52.65 | 4 | AbbVie Inc. ($15.76) |
| 2019 | $273.90 | 19 | Novo Nordisk Inc ($75.23) |
| 2018 | $379.92 | 21 | Regeneron Healthcare Solutions, Inc. ($116.97) |
| 2017 | $229.20 | 18 | SANOFI-AVENTIS U.S. LLC ($40.57) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.98 | General |
| Category: Cardiovascular | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Respiratory | ||||||
| 10/13/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: PAIN | ||||||
| 12/16/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 11/18/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes | ||||||
| 08/05/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $38.59 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Diabetes | ||||||
| 02/21/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: VACCINES | ||||||
| 02/14/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Respiratory | ||||||
| 01/29/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2019 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 11/01/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: UROLOGY | ||||||
| 10/06/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/27/2019 | Lilly USA, LLC | GLYXAMBI (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes | ||||||
| 09/13/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 09/05/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Diabetes | ||||||
| 07/19/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,462 | 2,286 | $314,993 | $136,153 |
| 2022 | 17 | 1,544 | 2,554 | $352,724 | $148,715 |
| 2021 | 17 | 1,588 | 2,683 | $340,319 | $187,469 |
| 2020 | 20 | 1,684 | 2,749 | $361,119 | $183,393 |
Total Patients
6,278
Total Services
10,272
Medicare Billing
$655,731
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 130 | 387 | $44,505 | $23,963 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 293 | 565 | $70,933 | $23,412 | 33.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 104 | 293 | $28,714 | $16,838 | 58.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 103 | 115 | $26,220 | $16,301 | 62.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 228 | 228 | $46,284 | $11,104 | 24.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 89 | 100 | $22,300 | $10,192 | 45.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 47 | 71 | $9,230 | $5,868 | 63.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 74 | 75 | $5,025 | $4,925 | 98.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 55 | 95 | $9,310 | $4,569 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 81 | $14,175 | $4,447 | 31.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 28 | 29 | $6,612 | $4,089 | 61.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 75 | 76 | $3,347 | $2,231 | 66.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,120 | $2,082 | 66.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 24 | 24 | $3,816 | $1,565 | 41.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 20 | 20 | $5,120 | $1,145 | 22.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 14 | $5,964 | $1,090 | 18.3% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 31 | 31 | $1,395 | $773.14 | 55.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $3,624 | $587.06 | 16.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $1,298 | $439.34 | 33.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 17 | 17 | $425.00 | $244.29 | 57.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 16 | 16 | $2,640 | $180.74 | 6.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $936.00 | $106.65 | 11.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 301 | 623 | $79,710 | $25,186 | 31.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 164 | 498 | $48,804 | $25,090 | 51.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 140 | 439 | $50,485 | $24,534 | 48.6% |
About Dr. Niraj Mistry, MD
Dr. Niraj Mistry, MD is a Internal Medicine healthcare provider based in Elyria, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528069952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niraj Mistry, MD has received a total of $1,172 in payments from pharmaceutical and medical device companies, with $39.42 received in 2024. These payments were reported across 74 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,169).
As a Medicare-enrolled provider, Mistry has provided services to 6,278 Medicare beneficiaries, totaling 10,272 services with total Medicare billing of $655,731. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Elyria, OH
- Active Since 08/09/2005
- Last Updated 10/05/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1528069952
Products in Payments
- PRALUENT ALIROCUMAB INJECTION (Biological) $116.97
- Tresiba (Drug) $72.09
- UBRELVY (Drug) $68.93
- ELIQUIS (Drug) $56.15
- SYMBICORT (Drug) $53.97
- Ozempic (Drug) $50.29
- MYRBETRIQ (Drug) $47.93
- Vascepa (Drug) $41.80
- SHINGRIX (Biological) $41.76
- Aimovig (Biological) $40.61
- LEQVIO (Drug) $39.01
- TRULICITY (Drug) $36.17
- QULIPTA (Drug) $32.24
- AFREZZA (Drug) $31.96
- LINZESS (Drug) $30.20
- ANORO (Drug) $28.10
- UTIBRON (Drug) $26.64
- SOLIQUA (Drug) $26.35
- GVOKE PFS (Drug) $24.28
- BYDUREON (Drug) $24.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elyria
Dr. Mehdi Shishehbor, Do, DO
Internal Medicine — Payments: $344,898
Internal Medicine $344,898
Ademola Abiose, Md, MD
Internal Medicine — Payments: $131,643
Internal Medicine $131,643
Dr. Sana Abumeri, M.d, M.D
Internal Medicine — Payments: $5,150
Internal Medicine $5,150
Dr. Norman Floro, Md, MD
Internal Medicine — Payments: $4,683
Internal Medicine $4,683
Vagesh Hampole, Md, MD
Internal Medicine — Payments: $1,521
Internal Medicine $1,521
Dr. Vijay Kakumanu, M.d, M.D
Internal Medicine — Payments: $1,393
Internal Medicine $1,393